Next Article in Journal
Enhanced Dissolution and Oral Bioavailability of Cyclosporine A: Microspheres Based on αβ-Cyclodextrins Polymers
Next Article in Special Issue
Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
Previous Article in Journal
Enhanced Solubility, Permeability and Anticancer Activity of Vorinostat Using Tailored Mesoporous Silica Nanoparticles
Previous Article in Special Issue
A Systematic Review and Critical Analysis of the Role of Graphene-Based Nanomaterials in Cancer Theranostics

HSA—Coated Magnetic Nanoparticles for MRI-Guided Photodynamic Cancer Therapy

Institute of Fine Chemical Technology, Moscow Technological University (MIREA), 86 Vernadsky Avenue, Moscow 119571, Russia
Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovitianov str. 1, Moscow 117997, Russia
Laboratory of Biomedical Nanomaterials, National Research Technological University “MISiS”, Leninskiy Prospekt 4, Moscow 119049, Russia
FSBI NMRRC of the Ministry of Health of the Russian Federation, 2-Y Botkinskiy Proyezd 3, Moscow 125284, Russia
Skolkovo Institute of Science and Technology, Nobelya Ulitsa 3, Moscow 121205, Russia
Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya sq., 9, Moscow 125047, Russia
Department of Chemistry, Moscow State University, Leninskie Gory 1/3, Moscow 119991, Russia
Author to whom correspondence should be addressed.
Pharmaceutics 2018, 10(4), 284;
Received: 5 November 2018 / Revised: 13 December 2018 / Accepted: 13 December 2018 / Published: 17 December 2018
(This article belongs to the Special Issue Nanotheranostics and Cancer: Where Are We Now?)
Background: Photodynamic therapy (PDT) is a promising technique for cancer treatment; however, low tissue permeability for irradiating light and insufficient photosensitizer (PS) accumulation in tumors limit its clinical potential. Nanoparticles are engineered to improve selective drug delivery to tumor sites, but its accumulation is highly variable between tumors and patients. Identifying PS accumulation peak in a personalized manner is crucial for therapeutic outcome. Magnetic nanoparticles (MNPs) provide opportunity for tracking drug accumulation in dynamics using non-invasive magnetic resonance imaging (MRI). The purpose of the study was to evaluate MNP loaded with PS as a theranostic tool for treating cancer in mice xenograft colon cancer models. Methods: MNPs coated with human serum albumin (HSA) were loaded with bacteriochlorine a. MRI, atomic emission spectroscopy (AES) and fluorescent imaging were used to study MNP and drug accumulation rates and dynamics in CT26 tumors. Tumor growth curves were evaluated in animals that received PDT at different time points upon MNP systemic injection. Results: Peak MNP accumulation in tumors was detected by MRI 60 min post injection (pi) and the data were verified by AES and fluorescent imaging. Up to 17% of injected dose/g of tissue was delivered to malignant tissues 24 h after injection. Consistent with MRI predicted drug accumulation peak PDT performed 60 min after intravenous injection was more efficient in inhibiting tumor growth than treatment scheduled 30 min and 240 min pi. Conclusions: PS loading on HAS-coated MNPs is a perspective approach to increase drug delivery to tumor site. Tracking for MNP accumulation by MRI can be used to predict drug concentration peak in tumors and to adjust PDT time scheduling for improved antitumor response. View Full-Text
Keywords: Photodynamic therapy; iron oxide nanoparticles; human serum albumin; MRI Photodynamic therapy; iron oxide nanoparticles; human serum albumin; MRI
Show Figures

Graphical abstract

MDPI and ACS Style

Ostroverkhov, P.; Semkina, A.; Naumenko, V.; Plotnikova, E.; Yakubovskaya, R.; Vodopyanov, S.; Abakumov, A.; Majouga, A.; Grin, M.; Chekhonin, V.; Abakumov, M. HSA—Coated Magnetic Nanoparticles for MRI-Guided Photodynamic Cancer Therapy. Pharmaceutics 2018, 10, 284.

AMA Style

Ostroverkhov P, Semkina A, Naumenko V, Plotnikova E, Yakubovskaya R, Vodopyanov S, Abakumov A, Majouga A, Grin M, Chekhonin V, Abakumov M. HSA—Coated Magnetic Nanoparticles for MRI-Guided Photodynamic Cancer Therapy. Pharmaceutics. 2018; 10(4):284.

Chicago/Turabian Style

Ostroverkhov, Petr, Alevtina Semkina, Victor Naumenko, Ekaterina Plotnikova, Raisa Yakubovskaya, Stepan Vodopyanov, Artem Abakumov, Alexander Majouga, Michael Grin, Vladimir Chekhonin, and Maxim Abakumov. 2018. "HSA—Coated Magnetic Nanoparticles for MRI-Guided Photodynamic Cancer Therapy" Pharmaceutics 10, no. 4: 284.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop